We polled our colleagues, picked through our stashes and interviewed experts to find 13 standout balms, gels, serums and more ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

Korean beauty and grooming products are known for their innovation; the rest of the world turns to Seoul for the next trend ...

The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first popularized in the 1990s.

Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...

The brand, which entered Target just two years ago, will no longer accept orders on its website after March 24.

Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...

Harsh, drying alcohol-based formulations of the past are out. Milky toners, that provide glow-giving skin barrier care, have ...

Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Apostrophe is being shut down to “simplify its (company’s) dermatology products and operations into one seamless experience,” Hims & Hers said. The telehealth company, which also offers products for ...

Hims & Hers Health (NYSE ... The company offers a minoxidil tablet for hair loss, as well as various skin care creams for both men and women. The shuttering of Apostrophe comes shortly after ...